128 related articles for article (PubMed ID: 38512344)
1. Acquired double-anaplastic lymphoma kinase rearrangement in lung adenocarcinoma after systemic chemotherapy.
Zhang J; Li H; Kong F
Panminerva Med; 2024 Mar; ():. PubMed ID: 38512344
[No Abstract] [Full Text] [Related]
2. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features and Therapeutic Responses of Chinese Patients with Advanced Lung Adenocarcinoma Harboring an Anaplastic Lymphoma Kinase Rearrangement.
Lin D; Zeng D; Chen C; Wu X; Wang M; Chen J; Lin H; Qiu X
Oncol Res Treat; 2017; 40(1-2):27-33. PubMed ID: 28118634
[TBL] [Abstract][Full Text] [Related]
4. Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database.
Matsuura Y; Mun M; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
J Surg Oncol; 2023 Oct; 128(5):916-924. PubMed ID: 37403534
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement.
Fu S; Wang HY; Wang F; Huang MY; Deng L; Zhang X; Ye ZL; Shao JY
Chin J Cancer; 2015 Aug; 34(9):404-12. PubMed ID: 26253541
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma.
Kamide Y; Kaira K; Watanabe T; Kuribayashi S; Ozawa A; Koga Y; Ono A; Sunaga N; Hisada T; Oyama T; Yamada M
Intern Med; 2015; 54(22):2905-9. PubMed ID: 26568007
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic lymphoma kinase rearrangement in surgically resected stage IA lung adenocarcinoma.
Shin SH; Lee H; Jeong BH; Choi YS; Shin MH; Kim S; Han J; Lee KS; Shim YM; Kwon OJ; Kim H
J Thorac Dis; 2018 Jun; 10(6):3460-3467. PubMed ID: 30069341
[TBL] [Abstract][Full Text] [Related]
9. [The application of conventional smears and liquid-based cytologic slides of lymphatic metastasis specimens of lung adenocarcinoma acquired by fine needle aspiration to detect the expression of anaplastic lymphoma kinase protein].
Jia J; Zhao LL; Guo HQ; Zhao H; Zhang ZH; Guo L; Ying JM
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):422-427. PubMed ID: 29936767
[No Abstract] [Full Text] [Related]
10. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
Matsuura Y; Ninomiya H; Ichinose J; Nakao M; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):441-451.e1. PubMed ID: 33131892
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement.
Nakajima N; Yoshizawa A; Kondo K; Rokutan-Kurata M; Hirata M; Furuhata A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Fujimoto M; Date H; Haga H
Histopathology; 2017 Jul; 71(1):143-149. PubMed ID: 28231386
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of anaplastic lymphoma kinase rearrangement in patients with completely resected lung adenocarcinoma.
Liu Y; Ye X; Yu Y; Lu S
J Thorac Dis; 2019 Oct; 11(10):4258-4270. PubMed ID: 31737311
[TBL] [Abstract][Full Text] [Related]
13. Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report.
Shirasawa M; Kubotaa M; Harada S; Niwa H; Kusuhara S; Kasajima M; Hiyoshi Y; Ishihara M; Igawa S; Masuda N
Lung Cancer; 2016 Sep; 99():66-8. PubMed ID: 27565916
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors.
Sim J; Kim H; Hyeon J; Choi Y; Han J
J Korean Med Sci; 2018 Apr; 33(15):e123. PubMed ID: 29629521
[TBL] [Abstract][Full Text] [Related]
15. [Crizotinib treatment for a lung adenocarcinoma patient with anaplastic lymphoma kinase gene rearrangement and disseminated intravascular coagulation].
Wang S; Li SM; Wu X; Zhu H; Wang QM
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1195-1196. PubMed ID: 34794223
[No Abstract] [Full Text] [Related]
16. Copy number gain in recurrent anaplastic lymphoma kinase (ALK) rearrangement-lung adenocarcinoma in the pleural effusion.
Abe H; Kawahara A; Azuma K; Murakami Y; Takase Y; Naito Y; Akiba J
Diagn Cytopathol; 2018 Sep; 46(9):744-747. PubMed ID: 29637735
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.
Harada D; Kozuki T; Nogami N; Bessho A; Hosokawa S; Fukamatsu N; Hotta K; Ohashi K; Kubo T; Yoshioka H; Yokoyama T; Sone N; Kuyama S; Kudo K; Yasugi M; Takigawa N; Oze I; Kiura K
Asia Pac J Clin Oncol; 2019 Aug; 15(4):250-256. PubMed ID: 30938103
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anaplastic lymphoma kinase-positive lung adenocarcinoma with pemetrexed and carboplatin after crizotinib failure and significant liver dysfunction; a case report.
Mohammadi O; Haines K; Jahanzeb M
Cancer Treat Res Commun; 2021; 26():100291. PubMed ID: 33388727
[TBL] [Abstract][Full Text] [Related]
19. Frequency of anaplastic lymphoma kinase rearrangements in Moroccan patients with non small cell lung cancer: a multi-institutional national retrospective study.
El Yacoubi H; Sow ML; Kettani F; Gamra L; Mestari A; Jabri L; Elghissassi I; Errihani H
BMC Cancer; 2020 May; 20(1):479. PubMed ID: 32460789
[TBL] [Abstract][Full Text] [Related]
20. [Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].
Caliez J; Monnet I; Pujals A; Rousseau-Bussac G; Jabot L; Boudjemaa A; Leroy K; Chouaid C
Rev Mal Respir; 2017 May; 34(5):576-580. PubMed ID: 27646667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]